PJP stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB).

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

The average market capitalization across the Invesco Pharmaceuticals ETF ETF is 115.04B. The market cap for tickers in the group ranges from 1.2B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is INVA at 1.2B.

The average weekly price growth across all stocks in the Invesco Pharmaceuticals ETF ETF was 8%. For the same ETF, the average monthly price growth was 17%, and the average quarterly price growth was 103%. PCRX experienced the highest price growth at 4%, while UTHR experienced the biggest fall at -9%.

The average weekly volume growth across all stocks in the Invesco Pharmaceuticals ETF ETF was -8%. For the same stocks of the ETF, the average monthly volume growth was 38% and the average quarterly volume growth was 58%